General MedicationsORALGeneric
DARVOCET
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
Standard Dose
325MG;32.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DARVOCET is listed in Drugs@FDA under application 016844 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE Form and strength TABLET;ORAL - 325MG;32.5MG Sponsor AAIPHARMA LLC Submission history Latest submission status date: 1972-10-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview DARVOCET is listed in Drugs@FDA under application 016844 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE Form and strength TABLET;ORAL - 325MG;32.5MG Sponsor AAIPHARMA LLC Submission history Latest submission status date: 1972-10-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.